Silverfin false false 31/03/2024 01/04/2023 31/03/2024 Clare Bent 03/04/2019 03 November 2024 The principal activity of the company is the provision of radiology services. 11923026 2024-03-31 11923026 bus:Director1 2024-03-31 11923026 2023-03-31 11923026 core:CurrentFinancialInstruments 2024-03-31 11923026 core:CurrentFinancialInstruments 2023-03-31 11923026 core:ShareCapital 2024-03-31 11923026 core:ShareCapital 2023-03-31 11923026 core:RetainedEarningsAccumulatedLosses 2024-03-31 11923026 core:RetainedEarningsAccumulatedLosses 2023-03-31 11923026 core:OfficeEquipment 2023-03-31 11923026 core:OfficeEquipment 2024-03-31 11923026 2023-04-01 2024-03-31 11923026 bus:FilletedAccounts 2023-04-01 2024-03-31 11923026 bus:SmallEntities 2023-04-01 2024-03-31 11923026 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11923026 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11923026 bus:Director1 2023-04-01 2024-03-31 11923026 core:OfficeEquipment core:TopRangeValue 2023-04-01 2024-03-31 11923026 2022-04-01 2023-03-31 11923026 core:OfficeEquipment 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Company No: 11923026 (England and Wales)

INTERVENTIONAL RADIOLOGY SERVICES LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2024
Pages for filing with the registrar

INTERVENTIONAL RADIOLOGY SERVICES LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2024

Contents

INTERVENTIONAL RADIOLOGY SERVICES LIMITED

BALANCE SHEET

As at 31 March 2024
INTERVENTIONAL RADIOLOGY SERVICES LIMITED

BALANCE SHEET (continued)

As at 31 March 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 4 8,942 0
8,942 0
Current assets
Cash at bank and in hand 61,955 52,961
61,955 52,961
Creditors: amounts falling due within one year 5 ( 10,888) ( 10,295)
Net current assets 51,067 42,666
Total assets less current liabilities 60,009 42,666
Net assets 60,009 42,666
Capital and reserves
Called-up share capital 100 100
Profit and loss account 59,909 42,566
Total shareholder's funds 60,009 42,666

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Interventional Radiology Services Limited (registered number: 11923026) were approved and authorised for issue by the Director on 03 November 2024. They were signed on its behalf by:

Clare Bent
Director
INTERVENTIONAL RADIOLOGY SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
INTERVENTIONAL RADIOLOGY SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Interventional Radiology Services Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England & Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, Cornwall, TR1 2NA.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Taxation

Current tax
Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible fixed assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Office equipment 3 years straight line
Leases

The Company as lessee
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Financial instruments

Classification

The company holds the following financial instruments:
• Short term trade and other debtors and creditors;
• Cash and bank balances.

All financial instruments are classified as basic.


Recognition and measurement

The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.

Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 0 0

3. Dividends on equity shares

2024 2023
£ £
Amounts recognised as distributions to equity holders in the financial year:
Final dividend for the financial year ended 31 March 2024 of £10 (2023: £20) per ordinary share 1,000 2,000

4. Tangible assets

Office equipment Total
£ £
Cost
At 01 April 2023 1,900 1,900
Additions 8,942 8,942
At 31 March 2024 10,842 10,842
Accumulated depreciation
At 01 April 2023 1,900 1,900
At 31 March 2024 1,900 1,900
Net book value
At 31 March 2024 8,942 8,942
At 31 March 2023 0 0

5. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 4,266 0
Taxation and social security 2,231 2,288
Other creditors 4,391 8,007
10,888 10,295

6. Related party transactions

Transactions with the entity's director

2024 2023
£ £
Amounts owing to director 2,352 6,087